Combined activity of ketoconazole and 5-fluorocytosine on potentially pathogenic yeasts.In vitro studies based on periodic viable count determinations indicated that the two antifungal drugs ketoconazole and 5-fluorocytosine generally were at least additive in their combined effect on various opportunistic yeast pathogens, including some resistant to 5-fluorocytosine
Non-suppression of cortisol secretion by long term treatment with ketoconazole in patients with acute leukaemia.Ketoconazole, a potent antifungal agent, inhibits adrenal steroidogenesis in normal subjects during short term treatment....
Ketoconazole pharmacokinetics in sudanese patients with mycetomaThe Plasma concentration of ketoconazole was assessed by estimation of the pharmacokinetic parameters for tow regimen 400 mg and 800 mg in mycetoma patients....
Orally administered ketoconazole: route of delivery to the human stratum corneum.Delivery of ketoconazole to human stratum corneum was studied....
